COPD: Simplifying a Complex Treatment Paradigm for Managed Care

Webinar Recorded on July 8, 2020 
Sponsored by GSK  

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the US, with total medical costs of COPD at nearly $50 billion.

The Global Initiative for Obstructive Disease (GOLD) 2020 report states that COPD is a treatable disease and highlights two specific treatable traits, which may impact various areas of disease burden. These are the patient:

• Symptoms, which link to quality of life, psychological functioning and mortality, and
• Exacerbations, which link to mortality, decline in lung function, quality of life, cardiovascular events and an enormous burden on the healthcare system.

This program covers these treatable traits, which guide pharmacotherapy to lessen the symptom burden and decrease risk of future exacerbations. Understanding these treatable traits can help managed care professionals ensure appropriate access to evidence-based approaches that allow HCPs to better diagnose patients and select optimal therapy.
 

Speaker:

• Tom Corbridge, MD, FCCP
  Emeritus Physician, Northwestern Memorial Hospital
  Adjunct Professor of Medicine
  Northwestern University, Feinberg School of Medicine
  US Medical Expert, Respiratory, GSK, Medical Affairs

This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. 

Sponsored by: